Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib

Summary

The purpose of this study is to assess the mass balance (i.e. cumulative excretion of total radioactivity \[TRA\] in urine and feces) of alisertib and pharmacokinetic (PK) of alisertib in plasma and urine, and of TRA in plasma and whole blood.

Timeline

Start

2013-01-24

Primary completion

2013-04-04

Completion

2013-06-14

Drugs

Indications